This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Study Finds Neurons And Support Cells Change Each Other For The Worse In Lou Gehrig's Disease

WASHINGTON, Feb. 4, 2013 /PRNewswire-USNewswire/ -- A study published in The Proceedings of the National Academy of Sciences USA has revealed that the disease process in amyotrophic lateral sclerosis (ALS) involves a complex genetic interplay between motor neurons and astrocytes. Motor neurons are the cells that die during the disease, leading to paralysis. Astrocytes normally support motor neurons but switch to the opposite role during disease progression. 

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. There is no cure and no life-prolonging treatments for the disease. 

"These results strengthen the case that astrocytes are central to the ALS disease process," said Lucie Bruijn, Ph.D., Chief Scientist for The ALS Association. "Furthermore, the results are based on an exciting new disease model system, one that will allow us to test important hypotheses and search for new therapeutic targets."

Funded in part by The Greater New York Chapter of The ALS Association and the Alabama Chapter of The ALS Association , the study was performed by Hemali Phatnani, Ph.D., and colleagues and led by Tom Maniatis, Ph.D., from Columbia University Medical Center in New York in partnership with colleagues at the HudsonAlpha Institute for Biotechnology in Huntsville, Ala. The study was conducted in a cell culture model of ALS derived from embryonic stem cells and in mouse models of ALS.

In this research, normal and diseased motor neurons and astrocytes were cultured together in various combinations and then separately analyzed. The authors tracked changes in the two types of cells by carefully identifying the RNA each cell type produced. RNA is a genetic messenger molecule that indicates which genes the cell is using at any moment. It was not previously possible to simultaneously examine gene changes over time in motor neurons and astrocytes in the same experimental system. Tracking the two cell types at the same time allowed the investigators to observe how changes in each cell type influence changes in the other. The communication between neurons and astrocytes "is profoundly disrupted" by the disease process, the researchers concluded.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs